Open access · OA
via OpenAlex
The Gut Microbiota, Neuroinflammation, and Cognitive Decline: Connecting Dysbiosis to Alzheimer’s Disease and Aging Brain Health
International Journal of Social Science and Economic Research · 2025
Abstract
Alzheimer's disease (AD) and cognitive decline in aging are increasingly linked with chronic neuroinflammation and gut microbiome alterations. Gut microbiome dysbiosis exacerbates the neuroinflammatory effects of aging and, by extension, cognitive deficits (Harach et al., 2017; Hung et al., 2022). This systematic review investigates how gut microbiota dysbiosis affects neuroinflammation and cognition in AD and aging-related cognitive decline. To this end, the prevalence of AD and cognitive decline in the aging population is assessed, and the microbiotagut-brain axis is identified as an underlying regulatory pathway of concern. Next, the means by which dysbiosis leads to CNS inflammatory response are detailed, including leaky gut, systemic inflammatory mediators, and microbiome metabolites such as lipopolysaccharides, SCFAs, amyloids, and bile acids. In humans, microbiota diversity is lower in AD patients, and microbiota generating SCFA are decreased, as are increased SCFA in AD patients, and younger patients with mild cognitive impairment (occurring sooner than normal) have dementia earlier in life than age-matched controls (Hung et al., 2022; Jemimah et al., 2023). This is observed in inflammatory markers in blood and cognitive assessments via standardized assessment tools. In animal models, gut microbiome modulation occurs via germ-free models, fecal transplant, and antibiotics or probiotics to see effects on amyloid burden and cognition (Harach et al., 2017; Zhang et al., 2023). Potential therapeutic interventions include dietary fiber, prebiotics, probiotics, synbiotics, and fecal microbiota transplantations with promising clinical outcomes (Akbari et al., 2016; Hung et al., 2022). The gut-brain axis is a potentially modifiable target to alleviate age-related cognitive decline or prevent its onset.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.46609/ijsser.2025.v10i11.016
- Canonical
- link ↗
- Fetched
- 2026-10-07 MST
Cite this
APA
Patel, K., & Bandi, L. (2025). The Gut Microbiota, Neuroinflammation, and Cognitive Decline: Connecting Dysbiosis to Alzheimer’s Disease and Aging Brain Health. <em>International Journal of Social Science and Economic Research</em>. https://doi.org/10.46609/ijsser.2025.v10i11.016
Vancouver
Patel K, Bandi L. The Gut Microbiota, Neuroinflammation, and Cognitive Decline: Connecting Dysbiosis to Alzheimer’s Disease and Aging Brain Health. International Journal of Social Science and Economic Research. 2025. doi:10.46609/ijsser.2025.v10i11.016.
BibTeX
@article{kaiyaa2025TheGut,
title = {The Gut Microbiota, Neuroinflammation, and Cognitive Decline: Connecting Dysbiosis to Alzheimer’s Disease and Aging Brain Health},
author = {Kaiyaa Patel and Laasya Bandi},
journal = {International Journal of Social Science and Economic Research},
year = {2025},
doi = {10.46609/ijsser.2025.v10i11.016},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Springer eBooks 2026
Citation only
Gut Dysbiosis in Alzheimer’s Disease: Insights from the Microbiome
Journal of Neuroinflammation 2019
Open access · CC-BY
Antibiotics, gut microbiota, and Alzheimer’s disease
Current nutrition reports 2026
Citation only
Gut Microbiota in Alzheimer's Disease and Healthy Aging: Mechanisms, Prevention Strategies and Healthcare Burden.
Experimental Gerontology 2024
Open access · CC-BY
Influence of human gut microbiome on the healthy and the neurodegenerative aging
Frontiers in Neurology 2023
Open access · CC-BY
Emerging role of gut microbiota dysbiosis in neuroinflammation and neurodegeneration
Gut 2022
Preprint · OA